Aytu Biopharma, Inc.
AYTU
$2.39
$0.0954.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 406.85% | -46.54% | 131.93% | -59.92% | -1,212.27% |
| Total Depreciation and Amortization | -1.64% | -6.17% | -26.59% | 26.81% | -14.41% |
| Total Amortization of Deferred Charges | -3.57% | 3.70% | -95.48% | 270.81% | 4.55% |
| Total Other Non-Cash Items | 35.05% | 24.55% | -349.92% | 269.86% | -129.25% |
| Change in Net Operating Assets | -411.97% | 510.33% | -1,790.48% | -102.44% | 137.95% |
| Cash from Operations | -322.20% | 344.12% | -51.02% | -210.24% | -88.15% |
| Capital Expenditure | -1,050.00% | 95.59% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -70.79% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 24.44% | 74.14% |
| Cash from Investing | -147.59% | -61.94% | 1,220.59% | 24.44% | 74.14% |
| Total Debt Issued | 2,431.78% | -113.76% | -86.43% | 76,644.44% | -- |
| Total Debt Repaid | 0.22% | -0.22% | 97.04% | -3,157.03% | 341.51% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 38.49% | -307.40% | -5.26% | -- | -- |
| Cash from Financing | 255.76% | -402.96% | -14.70% | 101.51% | 520.63% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -867.24% | 184.31% | -58.54% | 6.49% | 153.10% |